zur Navigation zum Inhalt
Hämatologie 9. Oktober 2013

Acute myeloid leukemia: highlights from the 54th ASH meeting held in Atlanta, Georgia

At the 2012 ASH meeting the topic “AML” was presented in the Ham–Wassermann lecture, an excellent educational symposium with numerous oral and poster presentations. Recent progress in the field of cytotoxic chemotherapy seems rather slow, but significant improvement in the understanding of the pathogenesis of acute myeloid leukemia (AML) has led to the identification of recurrent gene mutations; some of them already have changed treatment strategies in specific patients.

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben